Prognostic Value of Serum Markers in Gastric Cancer
Author Information
Author(s): I. Takahashi, Y. Maehara, T. Kusumoto, S. Kohno, Y. Kakeji, H. Baba, K. Sugimachi
Primary Institution: Kyushu University Hospital
Hypothesis
The combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels can predict the prognosis of gastric cancer patients.
Conclusion
The combined assay of serum sialyl-Tn antigen and carcinoembryonic antigen is useful for estimating the prognosis of gastric cancer patients.
Supporting Evidence
- Patients with high levels of both markers had a significantly lower 5-year survival rate.
- The study found no significant correlation between the two markers.
- Patients in the CEA (+) STN (+) group had more advanced disease characteristics.
Takeaway
Doctors can check two blood markers to see how serious someone's stomach cancer is and how well they might do after treatment.
Methodology
Serum levels of sialyl-Tn antigen and carcinoembryonic antigen were measured in 349 gastric cancer patients before surgery.
Limitations
The study only included Japanese patients, which may limit the generalizability of the findings.
Participant Demographics
349 Japanese patients with gastric cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website